NSAID-Associated Nephritis: Incidence and Clinical Significance
Nephritis secondary to daily moderate-dose NSAID use is uncommon but clinically significant, occurring in approximately 2% of chronic NSAID users who develop renal complications, though the absolute incidence of acute interstitial nephritis specifically is rare. 1
Quantifying the Risk
The renal complications from NSAIDs manifest in several forms, with varying frequencies:
Primary renal complications: Approximately 2% of persons taking NSAIDs discontinue them due to renal complications 1. This encompasses all forms of NSAID-related kidney injury, not just nephritis specifically.
Acute interstitial nephritis (AIN): This represents the true "nephritis" and is considerably rarer than other forms of NSAID-related kidney injury. While NSAIDs account for up to 15.6% of all drug-induced renal failure cases 2, acute interstitial nephritis specifically is an uncommon manifestation. The more common mechanism is hemodynamic renal insufficiency from prostaglandin inhibition 1.
Important distinction: Most NSAID-related renal dysfunction is hemodynamic (volume-dependent renal failure from prostaglandin inhibition affecting renal vasodilation), which is virtually always reversible 2. True interstitial nephritis and papillary necrosis are "relatively rare complications" but more often irreversible 2.
Clinical Context and Risk Factors
The risk is not uniform across all NSAID users. The renal system's dependence on prostaglandin-mediated vasodilation is more marked in persons with preexisting renal disease, congestive heart failure, or cirrhosis 1. Both selective COX-2 inhibitors and nonselective NSAIDs can cause these complications because COX-2 is important for renal prostaglandin production 1.
Medications that amplify risk: Beta blockers and ACE inhibitors may increase NSAID-related renal complications 1. The combination creates a "perfect storm" for acute kidney injury.
Practical Implications
Even correctly dosed NSAIDs can cause nephritis. In a pediatric cohort, 75% of children who developed NSAID-associated AKI received NSAIDs within recommended dosing limits 3. This underscores that "moderate dosage" does not eliminate risk—it's the cumulative exposure and individual susceptibility that matter.
The clinical presentation differs from antibiotic-induced interstitial nephritis: NSAID-induced nephritis shows more proteinuria, while eosinophilia, eosinophiluria, fever, and rash are less common compared to antibiotic-related cases 4.
Monitoring Recommendations
While the absolute incidence is low, some physician groups recommend baseline serum creatinine when starting NSAIDs in high-risk patients, with monitoring as often as weekly for three weeks after initiation in those taking concurrent ACE inhibitors or angiotensin receptor blockers 1. However, it remains unclear whether such monitoring improves morbidity or mortality 1.
Bottom Line for Clinical Practice
The incidence of true nephritis (interstitial nephritis) from daily moderate-dose NSAIDs is rare in the general population, but the 2% discontinuation rate for all renal complications represents a clinically meaningful risk 1. NSAIDs should be avoided entirely in persons with preexisting renal disease, congestive heart failure, or cirrhosis to prevent acute renal failure 1. When NSAIDs are necessary despite risk factors, use the lowest effective dose for the shortest duration 5, and maintain heightened vigilance for declining renal function.